NCT00131677View on ClinicalTrials.gov

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
HIV Infection
Interventions
DRUG

tenofovir disoproxil fumarate

study product taken daily

DRUG

placebo

study product taken daily

Trial Locations (3)

30308

AIDS Research Consortium of Atlanta, Atlanta

94102

San Francisco Department of Public Health, San Francisco

02115

Fenway Community Health, Boston

All Listed Sponsors
collaborator

San Francisco Department of Public Health

OTHER_GOV

collaborator

AIDS Research Consortium of Atlanta

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00131677 - Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men | Biotech Hunter | Biotech Hunter